Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells (Q28362305)

1

0 references

M Lundberg

2

0 references

J Avila-Cariño

3

0 references

G Jacobsson

4

0 references

A Scheynius

Clinical and Experimental Immunology

6

0 references

language of work or name

English

0 references

publication date

March 2001

0 references

published in

0 references

volume

123

0 references

issue

3

0 references

page(s)

350-60

0 references

cites work

A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Three-dimensional structure of recombinant human interferon-gamma

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Crystal structure of recombinant human interleukin-4

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Physiological functions of thioredoxin and thioredoxin reductase

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

CD30 ligand in lymphoma patients with CD30+ tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Redox regulation of cellular activation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Role for CD30 in HIV expression.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

CD30-mediated signaling promotes the development of human T helper type 2-like T cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

N-acetylcysteine: a new approach to anti-HIV therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

The physiological consequences of glutathione variations.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

A thiol antioxidant regulates IgE isotype switching by inhibiting activation of nuclear factor-kappaB.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Reverse signaling via CD30 ligand

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Mutated interleukin-5 monomers are biologically inactive

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Analysis of the conformation and stability of Escherichia coli derived recombinant human interleukin 4 by circular dichroism.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

N-acetylcysteine as chemoprotectant in cancer chemotherapy

2 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01453.X

Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD).

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01453.X

Functions of glutathione and glutathione disulfide in immunology and immunopathology.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906006

Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine

27 November 2018

1 reference

12 December 2020

N-acetylcysteine enhances T cell functions and T cell growth in culture

1 reference

12 December 2020

CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells

1 reference

12 December 2020

High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS

1 reference

12 December 2020

Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity

1 reference

12 December 2020

Detection of Pityrosporum orbiculare reactive T cells from skin and blood in atopic dermatitis and characterization of their cytokine profiles

1 reference

12 December 2020

Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma

1 reference

12 December 2020

Soluble CD30 in pediatric patients with atopic dermatitis

1 reference

12 December 2020

In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells

1 reference

12 December 2020

Allergen-induced CD30 expression on T cells of atopic asthmatics

1 reference

12 December 2020

Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis

1 reference

12 December 2020

In vivo relevance of CD30 in atopic dermatitis

1 reference

12 December 2020

Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines

1 reference

12 December 2020

Redox Control of Exofacial Protein Thiols/Disulfides by Protein Disulfide Isomerase

1 reference

12 December 2020

CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway

1 reference

12 December 2020

Alkaline phosphatase-fast red, a new fluorescent label. Application in double labelling for cell cycle analysis

1 reference

12 December 2020

Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation

1 reference

12 December 2020

N-acetylcysteine (NAC) enhances interleukin-2 but suppresses interleukin-4 secretion from normal and HIV+ CD4+ T-cells

1 reference

12 December 2020

CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition

1 reference

12 December 2020

Crosslinking of CD30 on activated human Th clones enhances their cytokine production and downregulates the CD30 expression

1 reference

12 December 2020

A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts

1 reference

12 December 2020

Glutathione regulates interleukin-2 activity on cytotoxic T-cells

1 reference

12 December 2020

BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope

1 reference

12 December 2020